WallStreetZenWallStreetZen

NASDAQ: OMGA
Omega Therapeutics Inc Earnings & Revenue

OMGA past revenue growth

How has OMGA's revenue growth performed historically?
Company
91.57%
Industry
169.3%
Market
17.86%
OMGA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OMGA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
OMGA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

OMGA earnings and revenue history

Current Revenue
$2.8M
Current Earnings
-$108.0M
Current Profit Margin
-3,802.9%

OMGA Return on Equity

Current Company
-107.8%
Current Industry
15.4%
Current Market
-8.4%
OMGA's Return on Equity (-107.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when OMGA announces earnings.

OMGA Return on Assets

Current Company
-57.7%
Current Industry
2.2%
OMGA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

OMGA Return on Capital Employed

Current Company
-57.91%
Current Industry
17.7%

OMGA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
OMGA$2.84M-$104.31M-$108.04M+91.57%N/A
AMLX$380.79M$55.39M$49.27M+304.24%N/A
RPTX$51.13M-$99.03M-$93.80M+722.89%N/A
PRQR$10.35M-$26.33M-$30.56M+9.83%N/A
IPHA$67.00M-$700.00k-$8.23M-8.70%N/A

OMGA earnings dates

Next earnings date
May 2, 2024

Omega Therapeutics Earnings & Revenue FAQ

What were OMGA's earnings last quarter?

On Invalid Date, Omega Therapeutics (NASDAQ: OMGA) reported Q3 2023 earnings per share (EPS) of -$0.40, up 25.93% year over year. Total Omega Therapeutics earnings for the quarter were -$22.25 million. In the same quarter last year, Omega Therapeutics's earnings per share (EPS) was -$0.54.

If you're new to stock investing, here's how to buy Omega Therapeutics stock.

What was OMGA's earnings growth in the past year?

As of Q1 2024, Omega Therapeutics's earnings has grown year over year. Omega Therapeutics's earnings in the past year totalled -$108.04 million.

What is OMGA's earnings date?

Omega Therapeutics's earnings date is Invalid Date. Add OMGA to your watchlist to be reminded of OMGA's next earnings announcement.

What was OMGA's revenue last quarter?

On Invalid Date, Omega Therapeutics (NASDAQ: OMGA) reported Q3 2023 revenue of $831.00 thousand up 39.66% year over year. In the same quarter last year, Omega Therapeutics's revenue was $595.00 thousand.

What was OMGA's revenue growth in the past year?

As of Q1 2024, Omega Therapeutics's revenue has grown 91.57% year over year. This is 77.73 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Omega Therapeutics's revenue in the past year totalled $2.84 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.